LST Biopharma Consulting SRL
LST Biopharma Consulting reported revenue of 6,464 € for the 2025 financial year (annual accounts filed with the NBB on 26 Sep 2026).
The score of LST Biopharma Consulting shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue -85 % Equity -99 % Total assets -91 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
LST Biopharma Consulting's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | 6,464 € | ||||
| Net result | −12,763 € | ||||
| Equity | 229 € | ||||
| Cash | 56 € | ||||
| EBITDA | −19,571 € | ||||
| Total assets | 6,084 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 26 Sep 2026
- Year ended 31 Dec 2024filed on 23 Sep 2025
- Year ended 31 Dec 2023filed on 30 Sep 2024
- Year ended 31 Dec 2022filed on 18 Nov 2023
- Year ended 31 Dec 2021filed on 30 Nov 2022
LST Biopharma Consulting's financial analysis
- Solvency3.8%sector median: 49.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of LST Biopharma Consulting
LST Biopharma Consulting's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0542.383.715
- VAT number
- BE0542383715
- Peppol
- Registered · 0208:0542383715 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Nov 2013
- Registered office
- 1370 Jodoigne
- Latest accounts
- 2025 · filed on 26 Sep 2026
- Activity
- Engineering activities and technical consultancy, except activities of land surveyors (NACE 71121)
LST Biopharma Consulting (SRL) has been based in Jodoigne since 2013, active in: engineering activities and technical consultancy, except activities of land surveyors. For 2025, it reports revenue of 6,464 €, a net loss of 12,763 € and equity of 229 €. Its solvency stands at 3.8%, below the median of its sector (49.7%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to LST Biopharma Consulting
Companies in the same business, of comparable size and area, outside its group.
- Atohmics Engineering activities and related technical consultancy Namur · balance sheet 5,042 €
- DNAlytics Engineering activities and related technical consultancy Ottignies-Louvain-la-Neuve · balance sheet 849,953 €
- Voredos Engineering activities and related technical consultancy Ramillies · balance sheet 302,169 €
- DNAlis Engineering activities and related technical consultancy Gembloux · balance sheet 45,804 €
- Pagoni Engineering activities and related technical consultancy Lubbeek · balance sheet 366,336 €
- 6FIT Engineering activities and related technical consultancy Chaumont-Gistoux · balance sheet 158,665 €
- Vixen Biosystems Research and experimental development on natural sciences and engineering Ghent · balance sheet €1.19m
- Audiengy Business and other management consultancy activities Wezembeek-Oppem · balance sheet 78,932 €
Frequently asked questions about LST Biopharma Consulting
What is the revenue of LST Biopharma Consulting?
According to the 2025 annual accounts filed with the NBB, the revenue of LST Biopharma Consulting amounts to 6,464 €.
What is the VAT number of LST Biopharma Consulting?
In Belgium, the VAT number is the company number prefixed with BE: BE0542383715 for LST Biopharma Consulting, if the company is VAT-registered. Its company number (CBE) is 0542.383.715.
Where is the registered office of LST Biopharma Consulting?
According to the CBE register, the registered office of LST Biopharma Consulting is in 1370 Jodoigne.
What is the equity of LST Biopharma Consulting?
At the close of the 2025 financial year, the equity of LST Biopharma Consulting amounts to 229 €, a solvency of 3.8% of total assets.
Who manages LST Biopharma Consulting?
The register lists 1 active mandates at LST Biopharma Consulting. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of LST Biopharma Consulting
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →